About Pearl Therapeutics Inc

Pearl was founded in 2006, with a mission to develop differentiated therapeutics for respiratory disease conditions prevalent worldwide, including chronic obstructive pulmonary disease (COPD). The product candidates currently being developed are based on the simple and widely prescribed metered-dose inhaler (MDI) dosage form. Company scientists have – more... 

Claim this company page
Headquarters
Morristown New Jersey, United States
Revenue
$26 Million
Employees
51 to 200
Industry
Links
Pearl Therapeutics Inc website